A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders / A. Eden Evins en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 6 (Diciembre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 6 (Diciembre) . - pp. 660-666 Título : A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders Tipo de documento: texto impreso Autores: A. Eden Evins, Autor ; Melissa A. Culhane, Autor ; Jonathan E. Alpert, Autor Fecha de publicación: 2023 Artículo en la página: pp. 660-666 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Bupropión, Terapia de modalidad combinada, Trastorno depresivo, Nicotina, Agonistas nicotínicos, Abandonos de pacientes, Tabaquismo, Dejar de fumar - métodos, Tabaquismo - Prevención, Trastorno por consumo de tabaco. Resumen: Although there is a strong relationship between depression and smoking, most nicotine dependence treatment trials exclude depressed smokers. Our objective was to determine whether bupropion improves abstinence rates and abstinence-associated depressive symptoms when added to transdermal nicotine replacement therapy (NRT) and group cognitive behavioral therapy (CBT) in smokers with unipolar depressive disorder (UDD). Link: ./index.php?lvl=notice_display&id=30825 [artículo] A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders [texto impreso] / A. Eden Evins, Autor ; Melissa A. Culhane, Autor ; Jonathan E. Alpert, Autor . - 2023 . - pp. 660-666. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 6 (Diciembre) . - pp. 660-666 Palabras clave: Bupropión, Terapia de modalidad combinada, Trastorno depresivo, Nicotina, Agonistas nicotínicos, Abandonos de pacientes, Tabaquismo, Dejar de fumar - métodos, Tabaquismo - Prevención, Trastorno por consumo de tabaco. Resumen: Although there is a strong relationship between depression and smoking, most nicotine dependence treatment trials exclude depressed smokers. Our objective was to determine whether bupropion improves abstinence rates and abstinence-associated depressive symptoms when added to transdermal nicotine replacement therapy (NRT) and group cognitive behavioral therapy (CBT) in smokers with unipolar depressive disorder (UDD). Link: ./index.php?lvl=notice_display&id=30825

A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia / A. Eden Evins en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 3 (Junio) . - pp. 218-225 Título : A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia Tipo de documento: texto impreso Autores: A. Eden Evins, Autor ; Corinne Cather, Autor ; Thilo Deckersbach, Autor Fecha de publicación: 2023 Artículo en la página: pp. 218-225 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Bupropión, Esquizofrenia, Tabaquismo, Fumar - metabolismo, Tabaquismo - psicología Resumen: The objective of this study was to examine the efficacy of bupropion for smoking cessation in patients with schizophrenia. Adults with schizophrenia who smoked more than 10 cigarettes per day and wished to try to quit smoking were recruited from community mental health centers, enrolled in a 12-week group cognitive behavioral therapy intervention, and randomly assigned to receive either bupropion sustained-release 300 mg/d or identical placebo. Link: ./index.php?lvl=notice_display&id=30905 [artículo] A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia [texto impreso] / A. Eden Evins, Autor ; Corinne Cather, Autor ; Thilo Deckersbach, Autor . - 2023 . - pp. 218-225. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 3 (Junio) . - pp. 218-225 Palabras clave: Bupropión, Esquizofrenia, Tabaquismo, Fumar - metabolismo, Tabaquismo - psicología Resumen: The objective of this study was to examine the efficacy of bupropion for smoking cessation in patients with schizophrenia. Adults with schizophrenia who smoked more than 10 cigarettes per day and wished to try to quit smoking were recruited from community mental health centers, enrolled in a 12-week group cognitive behavioral therapy intervention, and randomly assigned to receive either bupropion sustained-release 300 mg/d or identical placebo. Link: ./index.php?lvl=notice_display&id=30905

A double blind, placebo-controlled trial of the NMDA glycine site antagonist, gw468816, for prevention of relapse to smoking in females / A. Eden Evins en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 5 (Octubre) . - pp. 597-602 Título : A double blind, placebo-controlled trial of the NMDA glycine site antagonist, gw468816, for prevention of relapse to smoking in females Tipo de documento: texto impreso Autores: A. Eden Evins, Autor ; Gladys Pachas, Autor ; David Mischoulon, Autor Fecha de publicación: 2022 Artículo en la página: pp. 597-602 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Nicotina, Dejar de fumar, NMDA, Glutamato, Prevención de recaídas, Glicina Resumen: Relapse to smoking is common after initial abstinence with pharmacotherapy and behavioral support and represents a major clinical challenge. Although mechanisms underlying relapse to smoking have not been elucidated, preclinical studies suggest that glutamate receptors may be involved. Link: ./index.php?lvl=notice_display&id=29355 [artículo] A double blind, placebo-controlled trial of the NMDA glycine site antagonist, gw468816, for prevention of relapse to smoking in females [texto impreso] / A. Eden Evins, Autor ; Gladys Pachas, Autor ; David Mischoulon, Autor . - 2022 . - pp. 597-602. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 5 (Octubre) . - pp. 597-602 Palabras clave: Nicotina, Dejar de fumar, NMDA, Glutamato, Prevención de recaídas, Glicina Resumen: Relapse to smoking is common after initial abstinence with pharmacotherapy and behavioral support and represents a major clinical challenge. Although mechanisms underlying relapse to smoking have not been elucidated, preclinical studies suggest that glutamate receptors may be involved. Link: ./index.php?lvl=notice_display&id=29355

---

1 (1 - 3 / 3)